Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
European Crohn´s and Colitis Organisation - ECCO - Uncategorised
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
Palle BAGER | Clinical Nurse Specialist / Senior researcher / Associate Professor at Aarhus University | RN, MPH, PhD | Aarhus University Hospital, Århus | AUH | Department of Hepatology and Gastroenterology
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
ECCO in Vienna was the Best Congress Ever!
ECCO
Inflammatory Bowel Disease (IBD)
s of ECCO
WINTER
Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
NewsWINTER
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
PDF) Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris - Academia.edu
Inflammatory Bowel Diseases
